The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study
Breast Cancer Research and Treatment, 07/31/2012
Campana LG et al. – Electrochemotherapy (ECT) showed a satisfactory activity in refractory breast cancer chest wall recurrence (CWR), providing sustained local control. Patients with fewer and less scattered skin metastases are less likely to develop NL. Partial responders and new lesions (NL) can be handled with additional ECT albeit increasing local pain and skin toxicity.